In this research, a new ligand 3-((2-hydroxy-phenyl)imino)-2-(5-methoxy-3,3-dimethylindolin-2-ylidene) propanal (LOH) has been synthesized from 2-hydoxy aniline and 2-(5-methoxy-3,3-dimethylindolin-2-ylidene) malonaldehyde. The chemical structure of the synthesized ligand is identified by some spectroscopic techniques such as (FT-IR, 1H, 13C NMR, UV-Vis & C.H.N). The new ligand utilized to synthesis a set of complexes by its reaction with some of the transition elements salts. The synthesized complexes were identified using FT-IR, UV-Vis, atomic absorption, element analysis, magnetic susceptibility and conductivity measurements.
Complexes of Co(II), Ni(II), Cu(II) Zn(II), and Cd (II) with the ligand 3-(((2-amino-4-methylphenyl)imino)methyl)-4H-chromen-4-one derived 3-formyl chromone with 4-methyl-O-phenylenediamine were synthesized and characterized by elemental analysis, FTIR, electronic spectra, magnetic moment and molar conductance. The prepared complexes have the general formulae [M(C17H14N2O2)2]Cl2, M = Co(II), Ni(II), Cu(II) and Zn(II) except complex of cadmium it have the formulae [Cd(C17H14N2O2)Cl]Cl. The data which obtain from analysis indicate that the complexes have octahedral geometry around the metal center except cadmium complex exhibit tetrahedral geometry. Two types of bacteria (E.coli ) and (S. aureus ) used to estimate the biological activities of complexes .
This study includes two parts, and the first was the preparation of the Zn(II)complex by reacting N-[4-(5-{(Z)-[(5-oxo-2-sulfanyl-4,5-dihydro-1H-imidazol-1-yl)imino]methyl}furan-2-yl)phenyl]acetamide with ZnCl2. The complex was characterized by using microscopic analysis such as UV-Vis spectrum, LC-MS, FTIR spectrophotometer, measurements of conductivity, magnetic susceptibility, and atomic absorption. The second part was the preparation of the ZnO nanoparticles by dissolving the Zn(II) complex in HNO3 and HCl and its use as a drug transporter to treat leukemia. FSEM, TEM, and XRD were examined for the characterization of ZnO nanoparticles that will be used in the synthesis of most medicines and drugs in the future.
This research involved the synthesis of the ligand (E)-2-(2-oxoindolin-3-ylidene) hydrazinecarbothioamide (LM) from the reaction of indoline 2, 3-dione with thiosemicarbazide and characterization using 1HNMR, Uv-Vis, FT-IR, spectroscopy in addition to element analysis C.H.N. This ligand was utilize for the synthesizing of its metal ions complexes from its reaction with some salts of transition elements (CoCl2.6H2O, NiCl2.6H2O, CuCl2.2H2O, and ZnCl2). The newly prepared complexes [M(LM)2]Cl2 had been characterize by various techniques such as: (FTIR, UV-Vis, atomic absorption spectroscopy (A.A.), magnetic susceptibility and molar conductance). Both the ligand and the complexes tested for their biological activity against the Lymphocyte cells of humans in order to measure the Mitotic Index. The results showed that the effect of Zinc and Copper complexes on the rate of division of lymphocyte cells was higher compare with the effect of the Cobalt, Nickel complexes and the ligand utilizing a concentration of 100 μg/mL at 15 minutes of exposure. From that can be infer that the Copper and Zinc complexes was best and closest to colchicine for stopping lymphocyte division in the equatorial phase.